← All companies
Terns Pharmaceuticals, Inc.
TERN - CIK 0001831363
Market cap$6.12 B
Rank#1249
SEC filings430
The table below shows Terns Pharmaceuticals, Inc.'s balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $150.70M | $145.97M | $139.02M | $270.14M | $91.50M | $65.10M |
| Short-term investments | $144.94M | $169.48M | $195.24M | $102.64M | $133.80M | $175.56M |
| Receivables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Total current assets |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.